| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |